// App-Quantinova.ai

P1125 : CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

Researchers

Presenter

  • Loretta Nastoupil

Principal Investigators

  • Franck Morschhauser

  • Christian W. Scholz

  • Mark Bishton

  • Sung-Soo Yoon

  • Pratyush Giri

  • Michael C. Wei

  • Andrea Knapp

  • Chi-Chung Li

  • Alessia Bottos

  • Haocheng Li

  • Enkhtsetseg Purev

  • Nancy L. Bartlett

Medical Centers

  • Emory University,Atlanta,Stati Uniti

  • Hoffmann-La Roche Ltd,Mississauga, ON,Канада

  • Vivantes Klinikum am Urban,Berlin,Tyskland

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Emory University, Atlanta, Georgia, United States

  • Seoul National University Hospital, Seoul, Korea

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Nottingham University Hospitals NHS Trust, Nottingham,

  • Nottinghamshire University Hospitals NHS Trust,Nottingham,Vereinigtes Königreich

  • University of Lille and CHU de Lille, Lille, France

  • Vivantes Klinikum am Urban,Berlin,Tyskland

  • Seoul National University Hospital, Seoul, Korea

  • Roche - F.Hoffman-La Roche Ltd,Basel,Швейцария

  • Washington University School of Medicine, St. Louis, MO

  • Washin

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Vivantes Klinikum am Urban,Berlin,Tyskland

  • Vivantes Klinikum am Urban,Berlin,Tyskland

  • University of Lille,CHU Lille, Lille,Франция

  • Emory University,Atlanta, GA,Estados Unidos

  • Royal Adelaide Hospital, Adelaide, Australia

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Royal Adelaide Hospital, Adelaide, Australia

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • Emory University,Atlanta, GA,États-unis

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • Nottingham University Hospitals NHS Trust, Nottingham,

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Emory University,Atlanta,Verenigde Staten

  • Royal Adelaide Hospital, Adelaide, Australia

  • Genentech, Inc.,South San Francisco,Verenigde Staten

  • Vivantes Klinikum am Urban,Berlin,Tyskland

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • University of Lille, CHU Lille,

  • Vivantes Klinikum am Urban,Berlin,Tyskland

  • Royal Adelaide Hospital, Adelaide, Australia

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Genentech Inc.

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Emory University, Atlanta, GA

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • Emory University,Atlanta,Verenigde Staten

  • Seoul National University Bundang Hospital,Seongnam,Corée, République De

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, United States

  • Nottingham University Hospitals NHS Trust, Nottingham,

  • Washington University School of Medicine, St. Louis, MO

  • Royal Adelaide Hospital, Adelaide, Australia

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • Seoul National University Hospital,Seoul,Корея, южная

  • Washington University School of Medicine,St. Louis, MO,Vereinigte Staaten

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Vivantes Klinikum am Urban,Berlin,Tyskland

  • Genentech, Inc.,South San Francisco,Verenigde Staten

  • Washington University School of Medicine,St. Louis, MO,Vereinigte Staaten

  • Vivantes Klinikum am Urban,Berlin,Tyskland

  • Internal Medicine,Seoul National University Hospital ,Seoul,South Korea，Republic

  • Roche - F.Hoffman-La Roche Ltd,Basel,Швейцария

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • Vivantes Klinikum am Urban,Berlin,Германия

  • Genentech Inc., San Francisco, United States

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Seoul National University Hospital, Seoul, Korea

  • Washington University School of Medicine, St. Louis, MO

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • Royal Adelaide Hospital,Adelaide,Австралия

  • F. Hoffmann-La Roche Ltd ,Basel,Suisse

  • Nottingham University Hospitals NHS Trust, Nottingham,

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

Locations

  • United States

  • France

  • Germany

  • United Kingdom

  • Republic of South Korea

  • Australia

  • Switzerland

  • Canada

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

  • Rituximab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT02500407

  • NCT4246086

  • NCT04712097

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved